Lumateperone for Adult Stuttering
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests whether the drug lumateperone can help adults with stuttering, a speech disorder that began in childhood. If you have moderate or severe stuttering, this treatment might reduce symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with stuttering (childhood onset fluency disorder) that started before age 8.
- Your stuttering is moderate or severe as measured by a standard scale.
- You are willing to use reliable birth control during the study (if applicable).
- You can speak English.
- You do not have unstable medical, psychological, or neurological conditions, and your blood sugar (A1c) must be 6.4% or less.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a non‑invasive brain stimulation technique called transcranial magnetic stimulation (TMS) can help reduce stuttering. The trial involves sitting in a chair while a magnetic coil gently stimulates parts of your brain that control speech.
This study looks at how stuttering shows up, how severe it is, and possible ways to assess and treat it. It may help by giving you a chance to work with speech specialists and get a structured evaluation.
This study looks at how dopamine affects speech and movement in adults who stutter. It may help us understand why stuttering happens.
This trial tests a single dose of psilocybin, a psychedelic compound, to see if it can improve speech fluency and reduce struggle in adults who stutter. It also looks at changes in brain activity using fMRI scans. The study involves preparation sessions, a psilocybin session, and follow-up visits.
This study tests whether low-intensity focused ultrasound can change brain activity linked to stuttering. It may help people who have not had stuttering treatment in the past year.
This study tests a new medication called Lumateperone to see if it can reduce irritability in children and teens with autism. It's a 3-month trial that compares the study drug to a placebo (a pill with no active medicine) to find out if it helps with mood and behavior.
Hear when a new Stuttering, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.